How do pediatric patients perceive adverse drug events of anticonvulsant drugs? A survey

被引:6
作者
Neininger, Martina Patrizia [1 ,2 ]
Woltermann, Sarah [1 ,2 ,3 ]
Jeschke, Sarah [4 ]
Herziger, Birthe [4 ]
Mueller, Ruth Melinda [4 ]
Kiess, Wieland [3 ]
Bertsche, Thilo [1 ,2 ]
Bertsche, Astrid [3 ,4 ]
机构
[1] Univ Leipzig, Med Fac, Inst Pharm, Drug Safety Ctr, Bruderstr 32, D-04103 Leipzig, Germany
[2] Univ Leipzig, Med Fac, Inst Pharm, Clin Pharm, Bruderstr 32, D-04103 Leipzig, Germany
[3] Univ Hosp Children & Adolescents, Ctr Pediat Res, Liebigstr 20a, D-04103 Leipzig, Germany
[4] Univ Hosp Children & Adolescents, Neuropaediat, Ernst Heydemann Str 8, D-18057 Rostock, Germany
关键词
Adverse drug events (ADEs); Anticonvulsants; Children; Adolescents; Perceptions; Interview; SUDDEN UNEXPECTED DEATH; QUALITY-OF-LIFE; ANTIEPILEPTIC DRUGS; WEIGHT-GAIN; EPILEPSY; CHILDREN; ADOLESCENTS; OXCARBAZEPINE; VALPROATE; FEAR;
D O I
10.1007/s00431-020-03571-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Anticonvulsant drugs have a high risk of adverse drug events. Little is known about the perception of those events by pediatric patients. We performed a survey in the neuropediatric departments of two university hospitals. Using a questionnaire, we interviewed patients aged 6-18 years with current anticonvulsant treatment regarding (i) their fears about potential adverse drug events, (ii) experienced adverse drug events, and (iii) perceived burden of experienced adverse drug events. One hundred patients took part in the interview. (i) 40 (40%) expressed fears that the medication could harm them. Eighteen of 40 (45%) named fears concerning specific adverse drug events. Of those, 12/18 (67%) feared neurologic or psychiatric symptoms. (ii) 37 (37%) of children described altogether 60 experienced adverse drug events. Of those, 38 (63%) concerned neurologic or psychiatric symptoms. (iii) 32/37 (82%) children who experienced adverse drug events felt bothered by the experienced event. Among others, they described an emotional burden (11/37, 30%), and restrictions in school performance (8/37, 22%) and favorite leisure activities (4/37, 11%). Conclusion: School-aged children are well able to describe adverse drug events of their anticonvulsant medication. Almost two thirds of the described events concern neurologic or psychiatric symptoms that cause an emotional burden and restrictions according to the patients. What is Known: center dot Anticonvulsants have a high potential of adverse drug events. center dot In an earlier survey, parents expressed fears of severe adverse drug events such as liver failure, which seldom occur, and reported a high number of neurological and psychological adverse drug events. What is New: center dot Many children fear that their anticonvulsants could harm them, and they fear and experience neurological and psychological adverse drug events. center dot According to the children, adverse drug events cause an emotional burden and restrictions in school performance and favorite leisure activities.
引用
收藏
页码:1413 / 1420
页数:8
相关论文
共 50 条
  • [1] How do pediatric patients perceive adverse drug events of anticonvulsant drugs? A survey
    Martina Patrizia Neininger
    Sarah Woltermann
    Sarah Jeschke
    Birthe Herziger
    Ruth Melinda Müller
    Wieland Kiess
    Thilo Bertsche
    Astrid Bertsche
    European Journal of Pediatrics, 2020, 179 : 1413 - 1420
  • [2] How do parents perceive adverse drug events of their children's anticonvulsant medication?
    Bach, V. A.
    Neininger, M. P.
    Spindler, U. P.
    Hotopp, L. C.
    Hornemann, F.
    Syrbe, S.
    Merkenschlager, A.
    Kiess, W.
    Bernhard, M. K.
    Bertsche, T.
    Bertsche, A.
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2018, 22 (03) : 427 - 433
  • [3] Physicians' perspectives on adverse drug reactions in pediatric routine care: a survey
    Neininger, Martina P.
    Jeschke, Sarah
    Kiesel, Lisa M.
    Bertsche, Thilo
    Bertsche, Astrid
    WORLD JOURNAL OF PEDIATRICS, 2022, 18 (01) : 50 - 58
  • [4] Patterns of anticonvulsant use and adverse drug events in older adults
    Moura, Lidia M. V. R.
    Smith, Jason R.
    Yan, Zhiyu
    Blacker, Deborah
    Schwamm, Lee H.
    Newhouse, Joseph P.
    Hernandez-Diaz, Sonia
    Hsu, John
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (01) : 28 - 36
  • [5] Opioid-related Adverse Drug Events Do Parents Recognize the Signals?
    Voepel-Lewis, Terri
    Zikmund-Fisher, Brian
    Smith, Ellen L.
    Zyzanski, Sarah
    Tait, Alan R.
    CLINICAL JOURNAL OF PAIN, 2015, 31 (03) : 198 - 205
  • [6] Dermatologic Adverse Events in Pediatric Patients Receiving Targeted Anticancer Therapies: A Pooled Analysis
    Belum, Viswanath Reddy
    Washington, Courtney
    Pratilas, Christine A.
    Sibaud, Vincent
    Boralevi, Franck
    Lacouture, Mario E.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (05) : 798 - 806
  • [7] Greater Calcium Intake is Associated with Better Bone Health Measured by Quantitative Ultrasound of the Phalanges in Pediatric Patients Treated with Anticonvulsant Drugs
    Vera, Vicente
    Moran, Jose M.
    Barros, Patricia
    Canal-Macias, Maria L.
    Guerrero-Bonmatty, Rafael
    Costa-Fernandez, Carmen
    Lavado-Garcia, Jesus M.
    Roncero-Martin, Raul
    Pedrera-Zamorano, Juan D.
    NUTRIENTS, 2015, 7 (12): : 9908 - 9917
  • [8] Analysis of Adverse Drug Reactions in Pediatric Patients with Epilepsy: An Intensive Pharmacovigilance Study
    Hernandez Garcia, Ernestina
    Naranjo, Lizbeth
    Pichardo-Macias, Luz Adriana
    Bernad Bernad, Maria Josefa
    Castro-Pastrana, Lucila Isabel
    Ruiz Garcia, Matilde
    Garcia Bernal, Tanya Alejandra
    Solis, Jessica Lizbeth Mendoza
    Guzman, David Calderon
    Diaz-Garcia, Luisa
    Mendoza-Torreblanca, Julieta Griselda
    Chavez Pacheco, Juan Luis
    CHILDREN-BASEL, 2023, 10 (11):
  • [9] Comparison of Drug Utilization Patterns in Observational Data: Antiepileptic Drugs in Pediatric Patients
    Bourgeois, Florence T.
    Olson, Karen L.
    Poduri, Annapurna
    Mandl, Kenneth D.
    PEDIATRIC DRUGS, 2015, 17 (05) : 401 - 410
  • [10] Reactive metabolites of the anticonvulsant drugs and approaches to minimize the adverse drug reaction
    Pal, Rohit
    Singh, Karanvir
    Khan, Shah Alam
    Chawla, Pooja
    Kumar, Bhupinder
    Akhtar, Md Jawaid
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 226